Buscar
Mostrando ítems 1-2 de 2
A 13-Week, Randomized Double-Blind, Placebo-Controlled, Cross-Over Trial of Ziprasidone in Bipolar Spectrum Disorder
(LIPPINCOTT WILLIAMS & WILKINS, 2015)
Objective: Features of bipolarity in a major depressive disorder sample were used to define a "bipolar spectrum disorder" population for treatment with a neuroleptic agent, ziprasidone.
Methods: Forty-nine acutely ...
Mixed depression: A study of its phenomenology and relation to treatment response
(Elsevier, 2012)
Background: Mixed depression reflects the occurrence of a major depressive episode with subsyndromal
manic symptoms. Not recognized in DSM-IV, it is included in the proposed changes
for DSM-5. Observational and cross-sectional ...